William T. Harris

2.2k total citations
43 papers, 1.4k citations indexed

About

William T. Harris is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, William T. Harris has authored 43 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 6 papers in Surgery and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in William T. Harris's work include Cystic Fibrosis Research Advances (27 papers), Neonatal Respiratory Health Research (20 papers) and Tracheal and airway disorders (13 papers). William T. Harris is often cited by papers focused on Cystic Fibrosis Research Advances (27 papers), Neonatal Respiratory Health Research (20 papers) and Tracheal and airway disorders (13 papers). William T. Harris collaborates with scholars based in United States, United Kingdom and Australia. William T. Harris's co-authors include Steve Cunningham, Terry L. Noah, Margaret Rosenfeld, Warren E. Regelmann, Allen Lapey, Kevin W Southern, Gregory S. Sawicki, Jane C. Davies, John P. Clancy and Yulia Green and has published in prestigious journals such as Gastroenterology, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

William T. Harris

40 papers receiving 1.4k citations

Peers

William T. Harris
S Lanng Denmark
Anna Zolin Italy
Mary Corey Canada
Martin Stern Germany
Andrea Gramegna Italy
Anne E. O’Donnell United States
Rosa Girón Spain
Christine McCusker Canada
David de la Rosa Spain
Chee Y. Ooi Australia
S Lanng Denmark
William T. Harris
Citations per year, relative to William T. Harris William T. Harris (= 1×) peers S Lanng

Countries citing papers authored by William T. Harris

Since Specialization
Citations

This map shows the geographic impact of William T. Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William T. Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William T. Harris more than expected).

Fields of papers citing papers by William T. Harris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William T. Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William T. Harris. The network helps show where William T. Harris may publish in the future.

Co-authorship network of co-authors of William T. Harris

This figure shows the co-authorship network connecting the top 25 collaborators of William T. Harris. A scholar is included among the top collaborators of William T. Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William T. Harris. William T. Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Harris, William T., Elizabeth Baker, Jennifer S. Guimbellot, et al.. (2025). Tobacco smoke exposure is associated with diminished longitudinal benefit of elexacaftor/tezacaftor/ivacaftor in cystic fibrosis. Journal of Cystic Fibrosis. 24(5). 957–962.
3.
Vlasac, Irma, Diane Mellinger, Thomas H. Hampton, et al.. (2025). Lung-kidney axis in cystic fibrosis: Early urinary markers of kidney injury correlate with neutrophil activation and worse lung function. Journal of Cystic Fibrosis. 24(3). 613–620. 1 indexed citations
4.
5.
Oates, Gabriela R., et al.. (2021). Cessation of smoke exposure improves pediatric CF outcomes: Longitudinal analysis of CF Foundation Patient Registry data. Journal of Cystic Fibrosis. 20(4). 618–624. 5 indexed citations
6.
Baker, Elizabeth, et al.. (2020). Tobacco smoke exposure limits the therapeutic benefit of tezacaftor/ivacaftor in pediatric patients with cystic fibrosis. Journal of Cystic Fibrosis. 20(4). 612–617. 20 indexed citations
7.
Oates, Gabriela R., Elizabeth Baker, Steven M. Rowe, et al.. (2020). Tobacco smoke exposure and socioeconomic factors are independent predictors of pulmonary decline in pediatric cystic fibrosis. Journal of Cystic Fibrosis. 19(5). 783–790. 24 indexed citations
8.
Rosenfeld, Margaret, Steve Cunningham, William T. Harris, et al.. (2019). An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2–5 years (KLIMB). Journal of Cystic Fibrosis. 18(6). 838–843. 90 indexed citations
9.
Ambalavanan, Namasivayam, Kurt R. Zinn, Ambika P. Ashraf, et al.. (2017). Effect of Prenatal versus Postnatal Vitamin D Deficiency on Pulmonary Structure and Function in Mice. American Journal of Respiratory Cell and Molecular Biology. 56(3). 383–392. 34 indexed citations
10.
Ambalavanan, Namasivayam, Gang Liu, Peng Li, et al.. (2017). MicroRNA-145 Antagonism Reverses TGF-β Inhibition of F508del CFTR Correction in Airway Epithelia. American Journal of Respiratory and Critical Care Medicine. 197(5). 632–643. 50 indexed citations
11.
Westin, Erik, et al.. (2017). Pulmonary complications post hematopoietic stem cell transplant in dyskeratosis congenita: analysis of oxidative stress in lung fibroblasts. Bone Marrow Transplantation. 52(5). 765–768. 6 indexed citations
12.
Zemanick, Edith T., Brandie D. Wagner, Charles E. Robertson, et al.. (2017). Airway microbiota across age and disease spectrum in cystic fibrosis. European Respiratory Journal. 50(5). 1700832–1700832. 159 indexed citations
13.
Davies, Jane C., Steve Cunningham, William T. Harris, et al.. (2016). Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2–5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study. The Lancet Respiratory Medicine. 4(2). 107–115. 252 indexed citations
14.
Sun, Hongtao, William T. Harris, Kavitha Kotha, et al.. (2014). TGF-Beta Downregulation of Distinct Chloride Channels in Cystic Fibrosis-Affected Epithelia. PLoS ONE. 9(9). e106842–e106842. 58 indexed citations
15.
Schwiebert, Lisa M., Kim Estell, Victor J. Thannickal, et al.. (2014). Development and Maintenance of a Biospecimen Repository for Clinical Samples Derived from Pulmonary Patients. Clinical and Translational Science. 7(4). 336–341. 2 indexed citations
16.
Harris, William T., David R. Kelly, Yong Zhou, et al.. (2013). Myofibroblast Differentiation and Enhanced Tgf-B Signaling in Cystic Fibrosis Lung Disease. PLoS ONE. 8(8). e70196–e70196. 67 indexed citations
17.
Navaneethan, Udayakumar, et al.. (2012). Crohn's disease with pulmonary manifestations in children: 2 case reports and review of the literature. Journal of Crohn s and Colitis. 7(3). e85–e92. 11 indexed citations
18.
Harris, William T., Marianne S. Muhlebach, Robert A. Oster, et al.. (2011). Plasma TGF‐β1 in pediatric cystic fibrosis: Potential biomarker of lung disease and response to therapy. Pediatric Pulmonology. 46(7). 688–695. 57 indexed citations
19.
Patel, Mihir R., et al.. (2009). Experience of the school-aged child with tracheostomy. International Journal of Pediatric Otorhinolaryngology. 73(7). 975–980. 10 indexed citations
20.
Harris, William T., Marianne S. Muhlebach, Robert A. Oster, Michael R. Knowles, & Terry L. Noah. (2009). Transforming growth factor‐β1 in bronchoalveolar lavage fluid from children with cystic fibrosis. Pediatric Pulmonology. 44(11). 1057–1064. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S Lanng Breakdown of academic impact, for papers by Anna Zolin Breakdown of academic impact, for papers by Mary Corey Breakdown of academic impact, for papers by Martin Stern Breakdown of academic impact, for papers by Andrea Gramegna Breakdown of academic impact, for papers by Anne E. O’Donnell Breakdown of academic impact, for papers by Rosa Girón Breakdown of academic impact, for papers by Christine McCusker Breakdown of academic impact, for papers by David de la Rosa Breakdown of academic impact, for papers by Chee Y. Ooi
Rankless by CCL
2026